about
Therapeutic strategies targeting cancer stem cellsMetabolic reprogramming: the emerging concept and associated therapeutic strategiesLi-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapyIn Situ Characterization of Bak Clusters Responsible for Cell Death Using Single Molecule Localization Microscopy.Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation.EpCAM expression in the prostate cancer makes the difference in the response to growth factors.TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells.Three-dimensional culture of sebaceous gland cells revealing the role of prostaglandin E2-induced activation of canonical Wnt signaling.Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.The heterogeneity of cancer stem-like cells at the invasive frontEmerging role of epithelial-mesenchymal transition in hepatic cancer.Dynamic subcellular localization of aquaporin-7 in white adipocytes.[The emerging role of artificial intelligence in clinical and basic medicine]Beyond Stanton and Pott hypothesis; carbon nanotubes-induced malignant mesothelioma as a disease of gene lossEmergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise[Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis][Therapeutic strategy for breast cancer stem cells]Comment on "Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients"How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence?Emerging roles of Myc in stem cell biology and novel tumor therapiesComment on "GRP94 promotes brain metastasis by engaging pro-survival autophagy"Molecular machinery underlying the autophagic regulation by MDA-9/Syntenin leading to anoikis resistance of tumor cellsLegionnaires' disease as an occupational risk related to decontamination work after the Fukushima nuclear disaster: A case reportRegarding "Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms"Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic StrategiesSorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort StudyApplications of patient-derived tumor xenograft models and tumor organoids[Ⅰ. Molecular Mechanisms Underlying the Development and Progression of Malignant Melanoma]Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
P50
Q26781398-A4782A4E-F44C-4C1E-AE91-67A10CFCE4D4Q26786595-FD0CA683-AD45-4116-B266-27AEA5F43B60Q34432525-CB657D31-DF9F-4C37-A127-5E9288136EBBQ36996518-ED2EF32F-A96B-4ED6-A0C8-0520E8617249Q39044097-65408422-BDBF-44B1-9636-5BC45CA4D96DQ39048151-6EDB1C30-50EC-4F38-BFE6-7E656AB1B089Q39105341-5DC444E7-B26E-4998-B6DE-F6EFF2D9A448Q39109926-BE9F5198-43BA-44EA-875A-FB5775AAC91FQ39171305-140948AF-B8DE-46D5-9514-A386383CD322Q39335846-C6DCD8C5-56CC-4823-AF05-C65554DED451Q42321688-FF206666-041B-472D-B7F4-D96237F67330Q42395784-598A7AB0-8B64-4100-846D-91523DCE9726Q42830861-5FEAC92F-F8F4-42E6-BB1D-A7A7700C229FQ57050283-59B2C481-56AF-4793-BF78-4C298B98ACDFQ64240160-A655D30E-F8AA-47C5-B406-B09628147F05Q64240165-74A317E8-6661-4629-A002-E74A0B15DDD5Q83491825-E9BCD220-DA87-4D8D-89AA-2EE9EE2E9535Q85957104-AB78F791-3E5C-424C-A614-75DA43E1C98AQ89160748-521C5BA5-FFBB-4DC0-885C-F0ADDE74D5F5Q89241161-715F218B-072B-458C-805F-22FFA66578C9Q90576157-82673E2C-6C23-459B-8E12-6A454A5678D1Q90702112-6EB392A1-0A18-4A6A-BB23-DDE7E465B4E9Q90823887-93E5798C-52B9-4098-861B-D24CB483AF9EQ91026540-7E9B88BD-842E-4EDC-A22D-3E0DC19BAD6DQ91288491-EB8074DF-DF2B-482E-86AC-13DB991C2C30Q91857825-04A4F721-E6EF-467C-A72E-91A8606C60CCQ91928496-04CE7B5A-B72C-49B2-BC7F-ACB6C842FC14Q92476256-0429427A-026B-46DA-8A65-7BF2EB3D80C3Q94602786-50252276-FD9D-4869-B724-2A312B36366AQ96430352-A18142B3-F1C3-4027-A547-E12F92CF23EC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Go J Yoshida
@ast
Go J Yoshida
@en
Go J Yoshida
@es
Go J Yoshida
@nl
Go J Yoshida
@sl
type
label
Go J Yoshida
@ast
Go J Yoshida
@en
Go J Yoshida
@es
Go J Yoshida
@nl
Go J Yoshida
@sl
prefLabel
Go J Yoshida
@ast
Go J Yoshida
@en
Go J Yoshida
@es
Go J Yoshida
@nl
Go J Yoshida
@sl
P108
P106
P108
P31
P496
0000-0002-1472-892X